The stock market can be quite turbulent. Growth stocks, while having tremendous potential, can also be risky, as we have seen this month. The once-hyped AI growth stocks plummeted as investors failed to see adequate growth in comparison to their enormous capital expenditures. In such volatile scenarios, dividend stocks turn out to be a reliable source of income. When it comes to dependable income, few names carry the weight of Pfizer (PFE). After a rocky few years highlighted by post-pandemic revenue stabilization and pipeline shifts, PFE stock now offers something income investors rarely ignore: a dividend yield above 6%.
But yield isn’t the only factor to consider when choosing a dividend stock. Let’s find out if Pfizer is a high-quality dividend opportunity.
